News
Las acciones de Novo Nordisk caen un 23 % tras recortar previsiones y anunciar nuevo CEO; el mercado reacciona con fuerte castigo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results